国产冷冻设备(靶向刀)治疗肝癌临床应用  

Clinical application of domestic cryoablation device in the treatment of liver carcinomas

作　　者：王辅明 刘敬禹[1] 杨朝爱[1] 陈文会[1] 江旭[1] 杨继金[1] WANG Fuming;LIU Jingyu;YANG Chaoai;CHEN Wenhui;JIANG Xu;YANG Jijin.(Department of lnterventional Therapy, Affiliated Changhai Hospital, Second Military Medical University, Shanghai 200433, Chin)

机构地区：[1]第二军医大学附属长海医院介入科,上海200433

出　　处：《介入放射学杂志》2018年第6期530-533,共4页Journal of Interventional Radiology

基　　金：国家临床重点专科军队建设项目

摘　　要：目的 探讨国产靶向刀治疗肝癌方法 的近期疗效及安全性。方法 收集2016年6月1日至2017年6月30日于CT引导下行国产靶向刀冷冻消融治疗术的肝癌患者共计41例(52个病灶),通过MRI评价目标病灶完全消融率和近期的局部复发率及手术相关并发症。结果 41个病例完全消融率为90.2%,在平均约8个月的随访时间里,41例患者全部存活,术后3、6个月的累积局部复发率分别为17.1%、25.9%,所有患者均未出现严重并发症。结论 国产靶向刀治疗肝癌安全有效,能有效灭活局部瘤体。Objective To explore the clinical short-term efficacy and safety of the use of domestic eryoablation device （targeted knife） in treating liver carcinomas. Methods The clinical data of a total of 41 patients with liver carcinoma （52 lesions in total）, who received CT-guided cryoablation by using domestic cryoablation device during the period from June 1, 2016 to June 30, 2017, were collected. The complete ablation rate of target lesions, the short-term local recurrence rate and the surgery-related complications were evaluated with MRI. Results The complete ablation rate of the lesions in 41 patients was 90.2%. During an average follow-up period of about 8 months, all the 41 patients remained alive. The postoperative 3-month and 6-month cumulative local recurrence rates were 17.1% and 25.9% respectively, and no serious complieations occurred in all patients. Conclusion For the treatment of liver carcinomas, the use of domestic eryoablation device is safe and effective, it can effectively inactivate the local tumor.

关 键 词：肝癌 冷冻消融 靶向刀 国产 

分 类 号：R735.7[医药卫生—肿瘤]